Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:1841690.
doi: 10.1155/2016/1841690. Epub 2015 Dec 28.

Immune Cells and Inflammation in Diabetic Nephropathy

Affiliations
Review

Immune Cells and Inflammation in Diabetic Nephropathy

Zihan Zheng et al. J Diabetes Res. 2016.

Abstract

Diabetic nephropathy (DN) is a serious complication of diabetes. At its core, DN is a metabolic disorder which can also manifest itself in terms of local inflammation in the kidneys. Such inflammation can then drive the classical markers of fibrosis and structural remodeling. As a result, resolution of immune-mediated inflammation is critical towards achieving a cure for DN. Many immune cells play a part in DN, including key members of both the innate and adaptive immune systems. While these cells were classically understood to primarily function against pathogen insult, it has also become increasingly clear that they also serve a major role as internal sensors of damage. In fact, damage sensing may serve as the impetus for much of the inflammation that occurs in DN, in a vicious positive feedback cycle. Although direct targeting of these proinflammatory cells may be difficult, new approaches that focus on their metabolic profiles may be able to alleviate DN significantly, especially since dysregulation of the local metabolic environment may well be responsible for triggering inflammation to begin with. In this review, the authors consider the metabolic profile of several relevant immune types and discuss their respective roles.

PubMed Disclaimer

References

    1. Nathan D. M. Long-term complications of diabetes mellitus. The New England Journal of Medicine. 1993;328(23):1676–1685. doi: 10.1056/nejm199306103282306. - DOI - PubMed
    1. Ritz E., Orth S. R. Nephropathy in patients with type 2 diabetes mellitus. The New England Journal of Medicine. 1999;341(15):1127–1133. doi: 10.1056/nejm199910073411506. - DOI - PubMed
    1. Whiting D. R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011;94(3):311–321. doi: 10.1016/j.diabres.2011.10.029. - DOI - PubMed
    1. Gross J. L., de Azevedo M. J., Silveiro S. P., Canani L. H., Caramori M. L., Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–176. doi: 10.2337/diacare.28.1.164. - DOI - PubMed
    1. Zeisberg M., Neilson E. G. Mechanisms of tubulointerstitial fibrosis. Journal of the American Society of Nephrology. 2010;21(11):1819–1834. doi: 10.1681/asn.2010080793. - DOI - PubMed

Publication types

MeSH terms

Substances